225 related articles for article (PubMed ID: 28604162)
1. Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.
Erkes DA; Wilski NA; Snyder CM
Hum Vaccin Immunother; 2017 Aug; 13(8):1778-1785. PubMed ID: 28604162
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8
Tršan T; Vuković K; Filipović P; Brizić AL; Lemmermann NAW; Schober K; Busch DH; Britt WJ; Messerle M; Krmpotić A; Jonjić S
Eur J Immunol; 2017 Aug; 47(8):1354-1367. PubMed ID: 28612942
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
[TBL] [Abstract][Full Text] [Related]
4. Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.
Çuburu N; Bialkowski L; Pontejo SM; Sethi SK; Bell ATF; Kim R; Thompson CD; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2116738119. PubMed ID: 35749366
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.
Erkes DA; Xu G; Daskalakis C; Zurbach KA; Wilski NA; Moghbeli T; Hill AB; Snyder CM
Mol Ther; 2016 Aug; 24(8):1444-55. PubMed ID: 27434584
[TBL] [Abstract][Full Text] [Related]
6. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
Dirks J; Egli A; Sester U; Sester M; Hirsch HH
Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.
Murray SE; Nesterenko PA; Vanarsdall AL; Munks MW; Smart SM; Veziroglu EM; Sagario LC; Lee R; Claas FHJ; Doxiadis IIN; McVoy MA; Adler SP; Hill AB
J Exp Med; 2017 Jul; 214(7):1889-1899. PubMed ID: 28566275
[TBL] [Abstract][Full Text] [Related]
8. Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.
Wilski NA; Del Casale C; Purwin TJ; Aplin AE; Snyder CM
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375579
[TBL] [Abstract][Full Text] [Related]
9. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
10. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D
J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422
[TBL] [Abstract][Full Text] [Related]
11. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation.
Kato T; Nishida T; Ito Y; Murase M; Murata M; Naoe T
Cell Immunol; 2014; 288(1-2):53-9. PubMed ID: 24657340
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
[TBL] [Abstract][Full Text] [Related]
13. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.
Marashi SM; Raeiszadeh M; Enright V; Tahami F; Workman S; Chee R; Webster AD; Milne RS; Emery VC
J Allergy Clin Immunol; 2012 May; 129(5):1349-1356.e3. PubMed ID: 22444511
[TBL] [Abstract][Full Text] [Related]
15. Immune Protection by a Cytomegalovirus Vaccine Vector Expressing a Single Low-Avidity Epitope.
Borkner L; Sitnik KM; Dekhtiarenko I; Pulm AK; Tao R; Drexler I; Cicin-Sain L
J Immunol; 2017 Sep; 199(5):1737-1747. PubMed ID: 28768725
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
[TBL] [Abstract][Full Text] [Related]
17. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
18. An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.
Beswick M; Pachnio A; Al-Ali A; Sweet C; Moss PA
J Med Virol; 2013 Nov; 85(11):1968-74. PubMed ID: 23852921
[TBL] [Abstract][Full Text] [Related]
19. In vitro activation of CMV-specific human CD8(+) T cells by adenylate cyclase toxoids delivering pp65 epitopes.
Jelinek J; Adkins I; Mikulkova Z; Jagosova J; Pacasova R; Michlickova S; Sebo P; Michalek J
Bone Marrow Transplant; 2012 Feb; 47(2):243-50. PubMed ID: 21441962
[TBL] [Abstract][Full Text] [Related]
20. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.
Wang D; Fu TM
Curr Opin Virol; 2014 Jun; 6():13-23. PubMed ID: 24632198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
